Skip to main content

Bone Metastases from Prostate Cancer: Radiotherapy

Abstract

Radiotherapy is an effective treatment in patients with prostate cancer and metastatic bone disease. It has been in use for about a century, since radium has been found efficacious in the treatment of cancer. At the end of the 1960s, with the growth of high-energy radiation units, modern techniques of external beam irradiation (external beam radiation therapy (EBRT)) started to be routinely used. In subsequent years, technological evolution enabled the development of highly sophisticated treatment techniques, evolving from two-dimensional (2D) radiotherapy to three-dimensional conformal radiation therapy (3D-CRT) and, in the last two decades, to intensity-modulated radiation therapy (IMRT). IMRT main benefit is linked to the possibility to modulate the fluence of the beams, allowing an optimal dose distribution and enabling to irradiate structures with highly irregular shape close to critical organs [1, 2]. More recently, with the development of volumetric-modulated arc therapy (VMAT), an additional advantage in target volume coverage and normal tissue sparing has been reached, with a reduced treatment delivery time compared with IMRT [3, 4]. These techniques concur to improve tumor control and to reduce toxicity in the surrounding healthy tissues.

Keywords

  • Bone Metastasis
  • Zoledronic Acid
  • External Beam Radiation Therapy
  • Androgen Deprivation Therapy
  • Stereotactic Body Radiation Therapy

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-3-319-42327-2_14
  • Chapter length: 18 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   109.00
Price excludes VAT (USA)
  • ISBN: 978-3-319-42327-2
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   149.99
Price excludes VAT (USA)
Hardcover Book
USD   149.99
Price excludes VAT (USA)
Fig. 14.1
Fig. 14.2

References

  1. Webb S (2003) The physical basis of IMRT and inverse planning. Br J Radiol 76(910):678–689

    CAS  CrossRef  PubMed  Google Scholar 

  2. Intensity Modulated Radiation Therapy Collaborative Working Group (2001) Intensity-modulated radiotherapy: current status and issues of interest. Int J Radiat Oncol Biol Phys 51(4):880–914

    CrossRef  Google Scholar 

  3. Otto K (2008) Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys 35(1):310–317

    CrossRef  PubMed  Google Scholar 

  4. Teoh M, Clark CH, Wood K, Whitaker S, Nisbet A (2011) Volumetric modulated arc therapy: a review of current literature and clinical use in practice. Br J Radiol 84(1007):967–996

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  5. Baumann M, Krause M, Overgaard J, Debus J, Bentzen SM, Daartz J, Richter C, Zips D, Bortfeld T (2016) Radiation oncology in the era of precision medicine. Nat Rev Cancer 16(4):234–249

    CAS  CrossRef  PubMed  Google Scholar 

  6. Lo SS, Fakiris AJ, Chang EL, Mayr NA, Wang JZ, Papiez L, Teh BS, McGarry RC, Cardenes HR, Timmerman RD (2010) Stereotactic body radiation therapy: a novel treatment modality. Nat Rev Clin Oncol 7(1):44–54

    CrossRef  PubMed  Google Scholar 

  7. Dawson LA, Jaffray DA (2007) Advances in image-guided radiation therapy. J Clin Oncol 25(8):938–946

    CrossRef  PubMed  Google Scholar 

  8. Martin AG, Thomas SJ, Harden SV, Burnet NG (2015) Evaluating competing and emerging technologies for stereotactic body radiotherapy and other advanced radiotherapy techniques. Clin Oncol (R Coll Radiol) 27(5):251–259

    CAS  CrossRef  Google Scholar 

  9. Bubendorf L, Schöpfer A, Wagner U, Sauter G, Moch H, Willi N, Gasser TC, Mihatsch MJ (2000) Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 31(5):578–583

    CAS  CrossRef  PubMed  Google Scholar 

  10. Bhattasali O, Chen LN, Tong M, Lei S, Collins BT, Krishnan P, Kalhorn C, Lynch JH, Suy S, Dritschilo A, Dawson NA, Collins SP (2013) Rationale for stereotactic body radiation therapy in treating patients with oligometastatic hormone-naïve prostate cancer. Front Oncol 3:293

    CrossRef  PubMed  PubMed Central  Google Scholar 

  11. Denham JW, Joseph D, Lamb DS, Spry NA, Duchesne G, Matthews J, Atkinson C, Tai KH, Christie D, Kenny L, Turner S, Gogna NK, Diamond T, Delahunt B, Oldmeadow C, Attia J, Steigler A (2014) Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial. Lancet Oncol 15(10):1076–1089

    CAS  CrossRef  PubMed  Google Scholar 

  12. 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. (1999) Bone Pain Trial Working Party. Radiother Oncol 52(2):111–121

    Google Scholar 

  13. Steenland E, Leer JW, van Houwelingen H, Post WJ, van den Hout WB, Kievit J, de Haes H, Martijn H, Oei B, Vonk E, van der Steen-Banasik E, Wiggenraad RG, Hoogenhout J, Wárlám-Rodenhuis C, van Tienhoven G, Wanders R, Pomp J, van Reijn M, van Mierlo I, Rutten E (1999) The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 52(2):101–109

    CAS  CrossRef  PubMed  Google Scholar 

  14. van der Linden YM, Lok JJ, Steenland E, Martijn H, van Houwelingen H, Marijnen CA, Leer JW, Dutch Bone Metastasis Study Group (2004) Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment. Int J Radiat Oncol Biol Phys 59(2):528–537

    CrossRef  PubMed  Google Scholar 

  15. Hartsell WF, Scott CB, Bruner DW, Scarantino CW, Ivker RA, Roach M 3rd, Suh JH, Demas WF, Movsas B, Petersen IA, Konski AA, Cleeland CS, Janjan NA, DeSilvio M (2005) Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 97(11):798–804

    CrossRef  PubMed  Google Scholar 

  16. Sze WM, Shelley MD, Held I, Wilt TJ, Mason MD (2003) Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy--a systematic review of randomised trials. Clin Oncol (R Coll Radiol) 15(6):345–352

    CAS  CrossRef  Google Scholar 

  17. Wu JS, Wong R, Johnston M, Bezjak A, Whelan A, Cancer Care Ontario Practice Guidelines Initiative Supportive Care Group (2003) Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 55(3):594–605

    CrossRef  PubMed  Google Scholar 

  18. Chow E, Harris K, Fan G, Tsao M, Sze WM (2007) Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol 25(11):1423–1436

    CrossRef  PubMed  Google Scholar 

  19. Chow E, Zeng L, Salvo N, Dennis K, Tsao M, Lutz S (2012) Update on the systematic review of palliative radiotherapy trials for bone metastases. Clin Oncol (R Coll Radiol) 24(2):112–124

    CAS  CrossRef  Google Scholar 

  20. Roos DE, Turner SL, O'Brien PC, Smith JG, Spry NA, Burmeister BH, Hoskin PJ, Ball DL, Trans-Tasman Radiation Oncology Group, TROG 96.05 (2005) Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiother Oncol 75(1):54–63

    CrossRef  PubMed  Google Scholar 

  21. Dennis K, Makhani L, Zeng L, Lam H, Chow E (2013) Single fraction conventional external beam radiation therapy for bone metastases: a systematic review of randomised controlled trials. Radiother Oncol 106(1):5–14

    CrossRef  PubMed  Google Scholar 

  22. Fairchild A, Barnes E, Ghosh S, Ben-Josef E, Roos D, Hartsell W, Holt T, Wu J, Janjan N, Chow E (2009) International patterns of practice in palliative radiotherapy for painful bone metastases: evidence-based practice? Int J Radiat Oncol Biol Phys 75(5):1501–1510

    CrossRef  PubMed  Google Scholar 

  23. Popovic M, den Hartogh M, Zhang L, Poon M, Lam H, Bedard G, Pulenzas N, Lechner B, Chow E (2014) Review of international patterns of practice for the treatment of painful bone metastases with palliative radiotherapy from 1993 to 2013. Radiother Oncol 111(1):11–17

    CrossRef  PubMed  Google Scholar 

  24. Chow E, Hoskin PJ, Wu J, Roos D, van der Linden Y, Hartsell W, Vieth R, Wilson C, Pater J (2006) A phase III international randomised trial comparing single with multiple fractions for re-irradiation of painful bone metastases: National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) SC 20. Clin Oncol (R Coll Radiol) 18(2):125–128

    CAS  CrossRef  Google Scholar 

  25. Chow E, Wu JS, Hoskin P, Coia LR, Bentzen SM, Blitzer PH (2002) International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol 64(3):275–280

    CrossRef  PubMed  Google Scholar 

  26. Wong E, Hoskin P, Bedard G, Poon M, Zeng L, Lam H, Vulpe H, Tsao M, Pulenzas N, Chow E (2014) Re-irradiation for painful bone metastases: a systematic review. Radiother Oncol 110(1):61–70

    CrossRef  PubMed  Google Scholar 

  27. Huisman M, van den Bosch MA, Wijlemans JW, van Vulpen M, van der Linden YM, Verkooijen HM (2012) Effectiveness of reirradiation for painful bone metastases: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys 84(1):8–14

    CrossRef  PubMed  Google Scholar 

  28. International Bone Metastases Consensus Working Party (2001) International bone metastases consensus on endpoint measurements for future clinical trials: proceedings of the first survey and meeting (work in progress) International Bone Metastases Consensus Working Party. Clin Oncol (R Coll Radiol) 13(2):82–84

    Google Scholar 

  29. Chow E, Hoskin P, Mitera G, Zeng L, Lutz S, Roos D, Hahn C, van der Linden Y, Hartsell W, Kumar E, International Bone Metastases Consensus Working Party (2012) Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Int J Radiat Oncol Biol Phys 82(5):1730–1737

    CrossRef  PubMed  Google Scholar 

  30. Lutz S, Berk L, Chang E, Chow E, Hahn C, Hoskin P, Howell D, Konski A, Kachnic L, Lo S, Sahgal A, Silverman L, von Gunten C, Mendel E, Vassil A, Bruner DW, Hartsell W, American Society for Radiation Oncology (ASTRO) (2011) Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 79(4):965–976

    CrossRef  PubMed  Google Scholar 

  31. Chow E, van der Linden YM, Roos D, Hartsell WF, Hoskin P, Wu JS, Brundage MD, Nabid A, Tissing-Tan CJ, Oei B, Babington S, Demas WF, Wilson CF, Meyer RM, Chen BE, Wong RK (2014) Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial. Lancet Oncol 15(2):164–171

    CrossRef  PubMed  Google Scholar 

  32. Chow E, Ding K, Parulekar WR, Wong RK, van der Linden YM, Roos D, Hartsell WF, Hoskin P, Wu JS, Nabid A, Leer JW, Vonk E, Babington S, Demas WF, Wilson CF, Brundage M, Zhu L, Meyer RM. Predictive model for survival in patients having repeat radiation treatment for painful bone metastases. Radiother Oncol. 2016;118(3):547–51.

    Google Scholar 

  33. Byrne TN (1992) Spinal cord compression from epidural metastases. N Engl J Med 327(9):614–619

    CAS  CrossRef  PubMed  Google Scholar 

  34. Prasad D, Schiff D (2005) Malignant spinal-cord compression. Lancet Oncol 6(1):15–24

    CrossRef  PubMed  Google Scholar 

  35. Maranzano E, Bellavita R, Rossi R, De Angelis V, Frattegiani A, Bagnoli R, Mignogna M, Beneventi S, Lupattelli M, Ponticelli P, Biti GP, Latini P (2005) Short-course versus split-course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. J Clin Oncol 23(15):3358–3365

    CrossRef  PubMed  Google Scholar 

  36. Maranzano E, Trippa F, Casale M, Costantini S, Lupattelli M, Bellavita R, Marafioti L, Pergolizzi S, Santacaterina A, Mignogna M, Silvano G, Fusco V (2009) 8Gy single-dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiother Oncol 93(2):174–179

    CrossRef  PubMed  Google Scholar 

  37. Maranzano E, Trippa F, Casale M, Anselmo P, Rossi R (2011) Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiother Oncol 98(2):234–237

    CrossRef  PubMed  Google Scholar 

  38. Rades D, Lange M, Veninga T, Stalpers LJ, Bajrovic A, Adamietz IA, Rudat V, Schild SE (2011) Final results of a prospective study comparing the local control of short-course and long-course radiotherapy for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys 79(2):524–530

    CrossRef  PubMed  Google Scholar 

  39. Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, Mohiuddin M, Young B (2005) Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 366(9486):643–648

    CrossRef  PubMed  Google Scholar 

  40. Chi JH, Gokaslan Z, McCormick P, Tibbs PA, Kryscio RJ, Patchell RA (2009) Selecting treatment for patients with malignant epidural spinal cord compression-does age matter?: results from a randomized clinical trial. Spine (Phila Pa 1976) 34(5):431–435

    CrossRef  Google Scholar 

  41. Townsend PW, Smalley SR, Cozad SC, Rosenthal HG, Hassanein RE (1995) Role of postoperative radiation therapy after stabilization of fractures caused by metastatic disease. Int J Radiat Oncol Biol Phys 31(1):43–49

    CAS  CrossRef  PubMed  Google Scholar 

  42. Wolanczyk MJ, Fakhrian K, Adamietz IA (2016) Radiotherapy, bisphosphonates and surgical stabilization of complete or impending pathologic fractures in patients with metastatic bone disease. J Cancer Educ 7(1):121–124

    CrossRef  Google Scholar 

  43. Rowland CG, Bullimore JA, Smith PJ, Roberts JB (1981) Half-body irradiation in the treatment of metastatic prostatic carcinoma. Br J Urol 53(6):628–629

    CAS  CrossRef  PubMed  Google Scholar 

  44. Qasim MM (1981) Half body irradiation (HBI) in metastatic carcinomas. Clin Radiol 32(2):215–219

    CAS  CrossRef  PubMed  Google Scholar 

  45. Salazar OM, Scarantino CW (1997) Theoretical and practical uses of elective systemic (half-body) irradiation after 20 years of experimental designs. Int J Radiat Oncol Biol Phys 39(4):907–913

    CAS  CrossRef  PubMed  Google Scholar 

  46. Salazar OM, Rubin P, Hendrickson FR, Komaki R, Poulter C, Newall J, Asbell SO, Mohiuddin M, Van Ess J (1986) Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors. Final Radiation Therapy Oncology Group report. Cancer 58(1):29–36

    CAS  CrossRef  PubMed  Google Scholar 

  47. Berg RS, Yilmaz MK, Høyer M, Keldsen N, Nielsen OS, Ewertz M (2009) Half body irradiation of patients with multiple bone metastases: a phase II trial. Acta Oncol 48(4):556–561

    CAS  CrossRef  PubMed  Google Scholar 

  48. Salazar OM, DaMotta NW, Bridgman SM, Cardiges NM, Slawson RG (1996) Fractionated half-body irradiation for pain palliation in widely metastatic cancers: comparison with single dose. Int J Radiat Oncol Biol Phys 36(1):49–60

    CAS  CrossRef  PubMed  Google Scholar 

  49. Fitzpatrick PJ, Rider WD (1976) Half body radiotherapy. Int J Radiat Oncol Biol Phys 1(3–4):197–207

    CAS  CrossRef  PubMed  Google Scholar 

  50. Poulter CA, Cosmatos D, Rubin P, Urtasun R, Cooper JS, Kuske RR, Hornback N, Coughlin C, Weigensberg I, Rotman M (1992) A report of RTOG 8206: a phase III study of whether the addition of single dose hemibody irradiation to standard fractionated local field irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metastases. Int J Radiat Oncol Biol Phys 23(1):207–214

    CAS  CrossRef  PubMed  Google Scholar 

  51. Scarantino CW, Caplan R, Rotman M, Coughlin C, Demas W, Delrowe J (1996) A phase I/II study to evaluate the effect of fractionated hemibody irradiation in the treatment of osseous metastases-RTOG 88-22. Int J Radiat Oncol Biol Phys 36(1):37–48

    CAS  CrossRef  PubMed  Google Scholar 

  52. Bashir FA, Parry JM, Windsor PM (2008) Use of a modified hemi-body irradiation technique for metastatic carcinoma of the prostate: report of a 10-year experience. Clin Oncol (R Coll Radiol) 20(8):591–598

    CAS  CrossRef  Google Scholar 

  53. Salazar OM, Sandhu T, da Motta NW, Escutia MA, Lanzós-Gonzales E, Mouelle-Sone A, Moscol A, Zaharia M, Zaman S (2001) Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: a randomized Phase III trial of the International Atomic Energy Agency (IAEA). Int J Radiat Oncol Biol Phys 50(3):765–775

    CAS  CrossRef  PubMed  Google Scholar 

  54. Lin A, Ray ME (2006) Targeted and systemic radiotherapy in the treatment of bone metastasis. Cancer Metastasis Rev 25(4):669–675

    CrossRef  PubMed  Google Scholar 

  55. Hellman S, Weichselbaum RR (1995) Oligometastases. J Clin Oncol 13(1):8–10

    CAS  PubMed  Google Scholar 

  56. Timmerman RD, Bizekis CS, Pass HI, Fong Y, Dupuy DE, Dawson LA, Lu D (2009) Local surgical, ablative, and radiation treatment of metastases. CA Cancer J Clin 59(3):145–170

    CrossRef  PubMed  Google Scholar 

  57. Weichselbaum RR, Hellman S (2011) Oligometastases revisited. Nat Rev Clin Oncol 8(6):378–382

    CAS  PubMed  Google Scholar 

  58. Rubin P, Brasacchio R, Katz A (2006) Solitary metastases: illusion versus reality. Semin Radiat Oncol 16(2):120–130

    CrossRef  PubMed  Google Scholar 

  59. Bert C, Durante M (2014) Particle radiosurgery: a new frontier of physics in medicine. Phys Med 30(5):535–538

    CrossRef  PubMed  Google Scholar 

  60. Timmerman RD, Kavanagh BD, Cho LC, Papiez L, Xing L (2007) Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol 25(8):947–952

    CrossRef  PubMed  Google Scholar 

  61. Timmerman RD, Herman J, Cho LC (2014) Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice. J Clin Oncol 32(26):2847–2854

    CrossRef  PubMed  PubMed Central  Google Scholar 

  62. Potters L, Kavanagh B, Galvin JM, Hevezi JM, Janjan NA, Larson DA, Mehta MP, Ryu S, Steinberg M, Timmerman R, Welsh JS, Rosenthal SA, American Society for Therapeutic Radiology and Oncology; American College of Radiology (2010) American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 76(2):326–332

    CrossRef  PubMed  Google Scholar 

  63. Boda-Heggemann J, Lohr F, Wenz F, Flentje M, Guckenberger M (2011) kV cone-beam CT-based IGRT: a clinical review. Strahlenther Onkol 187(5):284–291

    CrossRef  PubMed  Google Scholar 

  64. Potters L, Gaspar LE, Kavanagh B, Galvin JM, Hartford AC, Hevezi JM, Kupelian PA, Mohiden N, Samuels MA, Timmerman R, Tripuraneni P, Vlachaki MT, Xing L, Rosenthal SA, American Society for Therapeutic Radiology and Oncology; American College of Radiology (2010) American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guidelines for image-guided radiation therapy (IGRT). Int J Radiat Oncol Biol Phys 76(2):319–325

    CrossRef  PubMed  Google Scholar 

  65. Alongi F, Arcangeli S, Filippi AR, Ricardi U, Scorsetti M (2012) Review and uses of stereotactic body radiation therapy for oligometastases. Oncologist 17(8):1100–1107

    CrossRef  PubMed  PubMed Central  Google Scholar 

  66. Milano MT, Katz AW, Zhang H, Okunieff P (2012) Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study. Int J Radiat Oncol Biol Phys 83(3):878–886

    CrossRef  PubMed  Google Scholar 

  67. Tree AC, Khoo VS, Eeles RA, Ahmed M, Dearnaley DP, Hawkins MA, Huddart RA, Nutting CM, Ostler PJ, van As NJ (2013) Stereotactic body radiotherapy for oligometastases. Lancet Oncol 14(1):e28–e37

    CrossRef  PubMed  Google Scholar 

  68. Sahgal A, Larson DA, Chang EL (2008) Stereotactic body radiosurgery for spinal metastases: a critical review. Int J Radiat Oncol Biol Phys 71(3):652–665

    CrossRef  PubMed  Google Scholar 

  69. Ryu S, Rock J, Rosenblum M, Kim JH (2004) Patterns of failure after single-dose radiosurgery for spinal metastasis. J Neurosurg 101(Suppl 3):402–405

    PubMed  Google Scholar 

  70. Chang EL, Shiu AS, Lii MF, Rhines LD, Mendel E, Mahajan A, Weinberg JS, Mathews LA, Brown BW, Maor MH, Cox JD (2004) Phase I clinical evaluation of near-simultaneous computed tomographic image-guided stereotactic body radiotherapy for spinal metastases. Int J Radiat Oncol Biol Phys 59(5):1288–1294

    CrossRef  PubMed  Google Scholar 

  71. Gerszten PC, Burton SA, Ozhasoglu C, Welch WC (2007) Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine (Phila Pa 1976) 32(2):193–199

    CrossRef  Google Scholar 

  72. Ryu S, Pugh SL, Gerszten PC, Yin FF, Timmerman RD, Hitchcock YJ, Movsas B, Kanner AA, Berk LB, Followill DS, Kachnic LA (2014) RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 results. Pract Radiat Oncol 4(2):76–81

    CrossRef  PubMed  Google Scholar 

  73. Wang XS, Rhines LD, Shiu AS, Yang JN, Selek U, Gning I, Liu P, Allen PK, Azeem SS, Brown PD, Sharp HJ, Weksberg DC, Cleeland CS, Chang EL (2012) Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial. Lancet Oncol 13(4):395–402

    CrossRef  PubMed  PubMed Central  Google Scholar 

  74. Moussazadeh N, Lis E, Katsoulakis E, Kahn S, Svoboda M, DiStefano NM, McLaughlin L, Bilsky MH, Yamada Y, Laufer I (2015) Five-year outcomes of high-dose single-fraction spinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 93(2):361–367

    CrossRef  PubMed  Google Scholar 

  75. Greco C, Zelefsky MJ, Lovelock M, Fuks Z, Hunt M, Rosenzweig K, Zatcky J, Kim B, Yamada Y (2011) Predictors of local control after single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases. Int J Radiat Oncol Biol Phys 79(4):1151–1157

    CrossRef  PubMed  Google Scholar 

  76. Yamada Y, Bilsky MH, Lovelock DM, Venkatraman ES, Toner S, Johnson J, Zatcky J, Zelefsky MJ, Fuks Z (2008) High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys 71(2):484–490

    CrossRef  PubMed  Google Scholar 

  77. Sahgal A, Ma L, Gibbs I, Gerszten PC, Ryu S, Soltys S, Weinberg V, Wong S, Chang E, Fowler J, Larson DA (2010) Spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 77(2):548–553

    CrossRef  PubMed  Google Scholar 

  78. Fowler JF (2010) 21 years of biologically effective dose. Br J Radiol 83(991):554–568

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  79. Hamilton AJ, Lulu BA, Fosmire H, Stea B, Cassady JR (1995) Preliminary clinical experience with linear accelerator-based spinal stereotactic radiosurgery. Neurosurgery 36(2):311–319

    CAS  CrossRef  PubMed  Google Scholar 

  80. Ryu S, Fang Yin F, Rock J, Zhu J, Chu A, Kagan E, Rogers L, Ajlouni M, Rosenblum M, Kim JH (2003) Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis. Cancer 97(8):2013–2018

    CrossRef  PubMed  Google Scholar 

  81. Milker-Zabel S, Zabel A, Thilmann C, Schlegel W, Wannenmacher M, Debus J (2003) Clinical results of retreatment of vertebral bone metastases by stereotactic conformal radiotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 55(1):162–167

    CrossRef  PubMed  Google Scholar 

  82. Sahgal A, Ames C, Chou D, Ma L, Huang K, Xu W, Chin C, Weinberg V, Chuang C, Weinstein P, Larson DA (2009) Stereotactic body radiotherapy is effective salvage therapy for patients with prior radiation of spinal metastases. Int J Radiat Oncol Biol Phys 74(3):723–731

    CrossRef  PubMed  Google Scholar 

  83. Sahgal A, Ma L, Weinberg V, Gibbs IC, Chao S, Chang UK, Werner-Wasik M, Angelov L, Chang EL, Sohn MJ, Soltys SG, Létourneau D, Ryu S, Gerszten PC, Fowler J, Wong CS, Larson DA (2012) Reirradiation human spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 82(1):107–116

    CrossRef  PubMed  Google Scholar 

  84. Thibault I, Campbell M, Tseng CL, Atenafu EG, Letourneau D, Yu E, Cho BC, Lee YK, Fehlings MG, Sahgal A (2015) Salvage Stereotactic Body Radiotherapy (SBRT) following in-field failure of initial SBRT for spinal metastases. Int J Radiat Oncol Biol Phys 93(2):353–360

    CrossRef  PubMed  Google Scholar 

  85. Rock JP, Ryu S, Shukairy MS, Yin FF, Sharif A, Schreiber F, Abdulhak M, Kim JH, Rosenblum ML (2006) Postoperative radiosurgery for malignant spinal tumors. Neurosurgery 58(5):891–898; discussion 891–898

    CrossRef  PubMed  Google Scholar 

  86. Gerszten PC, Germanwala A, Burton SA, Welch WC, Ozhasoglu C, Vogel WJ (2005) Combination kyphoplasty and spinal radiosurgery: a new treatment paradigm for pathological fractures. J Neurosurg Spine 3(4):296–301

    CrossRef  PubMed  Google Scholar 

  87. Singh D, Yi WS, Brasacchio RA, Muhs AG, Smudzin T, Williams JP, Messing E, Okunieff P (2004) Is there a favorable subset of patients with prostate cancer who develop oligometastases? Int J Radiat Oncol Biol Phys 58(1):3–10

    CrossRef  PubMed  Google Scholar 

  88. Schweizer MT, Zhou XC, Wang H, Yang T, Shaukat F, Partin AW, Eisenberger MA, Antonarakis ES (2013) Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy. Ann Oncol 24(11):2881–2886

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  89. Ost P, Decaestecker K, Lambert B, Fonteyne V, Delrue L, Lumen N, Ameye F, De Meerleer G (2014) Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancer. Prostate 74(3):297–305

    CAS  CrossRef  PubMed  Google Scholar 

  90. Berkovic P, De Meerleer G, Delrue L, Lambert B, Fonteyne V, Lumen N, Decaestecker K, Villeirs G, Vuye P, Ost P (2013) Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy. Clin Genitourin Cancer 11(1):27–32

    CrossRef  PubMed  Google Scholar 

  91. Decaestecker K, De Meerleer G, Lambert B, Delrue L, Fonteyne V, Claeys T, De Vos F, Huysse W, Hautekiet A, Maes G, Ost P (2014) Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence. Radiat Oncol 9:135

    CrossRef  PubMed  PubMed Central  Google Scholar 

  92. Muacevic A, Kufeld M, Rist C, Wowra B, Stief C, Staehler M (2013) Safety and feasibility of image-guided robotic radiosurgery for patients with limited bone metastases of prostate cancer. Urol Oncol 31(4):455–460

    CrossRef  PubMed  Google Scholar 

  93. Ahmed KA, Barney BM, Davis BJ, Park SS, Kwon ED, Olivier KR (2013) Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer. Front Oncol 2:215

    CrossRef  PubMed  PubMed Central  Google Scholar 

  94. Ost P, Jereczek-Fossa BA, As NV, Zilli T, Muacevic A, Olivier K, Henderson D, Casamassima F, Orecchia R, Surgo A, Brown L, Tree A, Miralbell R, De Meerleer G (2016) Progression-free survival following stereotactic body radiotherapy for oligometastatic prostate cancer treatment-naive recurrence: a multi-institutional analysis. Eur Urol 69(1):9–12

    CrossRef  PubMed  Google Scholar 

  95. Pasqualetti F, Panichi M, Sainato A, Matteucci F, Galli L, Cocuzza P, Ferrazza P, Coraggio G, Pasqualetti G, Derosa L, Sollini M, Mannelli L, Ortori S, Monzani F, Ricci S, Greco C, Fabrini MG, Erba PA (2016) [(18)F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results. Radiat Oncol 11(1):9

    CrossRef  PubMed  PubMed Central  Google Scholar 

  96. Decaestecker K, De Meerleer G, Ameye F, Fonteyne V, Lambert B, Joniau S, Delrue L, Billiet I, Duthoy W, Junius S, Huysse W, Lumen N, Ost P (2014) Surveillance or metastasis-directed Therapy for Oligometastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial. BMC Cancer 14:671

    CrossRef  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Barbara Avuzzi .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Avuzzi, B., Valdagni, R. (2017). Bone Metastases from Prostate Cancer: Radiotherapy. In: Bertoldo, F., Boccardo, F., Bombardieri, E., Evangelista, L., Valdagni, R. (eds) Bone Metastases from Prostate Cancer . Springer, Cham. https://doi.org/10.1007/978-3-319-42327-2_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-42327-2_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-42326-5

  • Online ISBN: 978-3-319-42327-2

  • eBook Packages: MedicineMedicine (R0)